Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT8826LA | OT / RA |
inadvertent administration of fluzone np instead of the intended fluad hd to a 66 year old patient with no adverse event; Initial information received on 20-Nov-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 66-year-old female patient who was inadvertent administration of influenza USP trival A-B subvirion no preservative vaccine [Fluzone] instead of the intended fluad hd with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.no other immunizations On 20-Nov-2025 at approximately 9:45 AM , the patient received a 0.5 ml dose of suspect Influenza USP Trival A-B Subvirion No Preservative Vaccine Suspension for injection strength: standard of lot UT8826LA and expiry date: 30-Jun-2026 via intramuscular route in the right deltoid for Influenza (Influenza immunization) instead of the intended fluad hd to a 66 year old patient with no adverse event (wrong product administered) (latency: on same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.